PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Strojek K et al. – With respect to HbA1c, BIAsp 30 fulfilled the statistical criteria for non–inferiority and superiority to insulin glargine and, according to pre–defined criteria, the improvements in HbA1c are considered clinically equivalent. Subjects had an increased risk of minor nocturnal hypoglycemia with BIAsp 30. There were no differences in treatment satisfaction between the two groups.

Exclusive Author Commentary
Krzysztof Strojek, 10/22/09

Hypoglycemic treatment of type 2 diabetic patients must be focused on normalization of blood glucose without adverse effects. The study showed that initiation of insulin should be individualized. Both algorithms brought the similar treatment satisfaction while BIAsp30 was associated with better glycemic control. On the other hand in the group of patients with higher risk of hypoglycemia, especially nocturnal, insulin initiation with glargine should be considered as alternative option.

Today in Endocrinology...keeping you current

The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/10/09

False Positive test Results for Pheochromocytoma from 2000 to 2008
Experimental and Clinical Endocrinology & Diabetes, 12/10/09

Does Normal Thyroid Gland by Ultrasonography match with Normal Serum Thyroid Hormones and Negative Thyroid Antibodies
Experimental and Clinical Endocrinology & Diabetes, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address